-
1دورية أكاديمية
المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, MarÃa J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, Galamaga, Rob
المصدر: ENT and Skull Base Surgery
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Progression-Free Survival, Protein Kinase Inhibitors, Quinolines, Sunitinib, Survival Analysis
الإتاحة: https://doi.org/10.1056/NEJMoa2035716Test
https://scholar.barrowneuro.org/ent-and-skull-base-surgery/23Test -
2دورية أكاديمية
المؤلفون: Rha, Sun Young, Choueiri, Toni K., Matveev, Vsevolod B., Alyasova, Anna, Hong, Sung‐Hoo, Gordoa, Teresa Alonso, Gurney, Howard, Bjarnason, Georg A., Buchler, Tomas, Pedrazzoli, Paolo, Takagi, Toshio, Park, Se Hoon, Lee, Jae Lyun, Perini, Rodolfo F., He, Cixin S., McKenzie, Jodi A., Eto, Masatoshi
المصدر: International Journal of Cancer; Sep2023, Vol. 153 Issue 6, p1241-1250, 10p
مصطلحات موضوعية: SUNITINIB, HAND-foot syndrome, RENAL cell carcinoma, PEMBROLIZUMAB, PROTEIN-tyrosine kinase inhibitors, PLATELET count, PATIENT safety
مصطلحات جغرافية: EAST Asia, SOUTH Korea
-
3دورية أكاديمية
المؤلفون: Motzer, Robert, Porta, Camillo, Alekseev, Boris, Rha, Sun Young, Choueiri, Toni K, Mendez-Vidal, Maria Jose, Hong, Sung-Hoo, Kapoor, Anil, Goh, Jeffrey C, Eto, Masatoshi, Bennett, Lee, Wang, Jinyi, Pan, Jie Janice, Saretsky, Todd L, Perini, Rodolfo F, He, Cixin Steven, Mody, Kalgi, Cella, David
المساهمون: Motzer, Robert, Porta, Camillo, Alekseev, Bori, Rha, Sun Young, Choueiri, Toni K, Mendez-Vidal, Maria Jose, Hong, Sung-Hoo, Kapoor, Anil, Goh, Jeffrey C, Eto, Masatoshi, Bennett, Lee, Wang, Jinyi, Pan, Jie Janice, Saretsky, Todd L, Perini, Rodolfo F, He, Cixin Steven, Mody, Kalgi, Cella, David
مصطلحات موضوعية: CLEAR study, lenvatinib, pembrolizumab, sunitinib, progression-free survival, overall survival, advanced renal cell carcinoma
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35489363; info:eu-repo/semantics/altIdentifier/wos/WOS:000831830800022; volume:23; issue:6; firstpage:768; lastpage:780; numberofpages:13; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/11586/464740Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131115613
الإتاحة: https://doi.org/10.1016/s1470-2045Test(22)00212-1
https://hdl.handle.net/11586/464740Test -
4دورية أكاديمية
المؤلفون: Rini, Brian I, Plimack, Elizabeth R, Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzhanivska, Anna, Bondarenko, Igor, Azevedo, Sergio J, Borchiellini, Delphine, Szczylik, Cezary, Markus, Maurice, McDermott, Raymond S, Bedke, Jens, Tartas, Sophie, Chang, Yen-Hwa, Tamada, Satoshi, Shou, Qiong, Perini, Rodolfo F, Chen, Mei, Atkins, Michael B, Powles, Thomas, Nair, Suresh G., MD
المصدر: Hematology-Medical Oncology Division
مصطلحات موضوعية: Administration, Intravenous, Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Axitinib, Carcinoma, Renal Cell, Female, Humans, Intention to Treat Analysis, Kidney Neoplasms, Male, Middle Aged, Programmed Cell Death 1 Receptor, Progression-Free Survival, Single-Blind Method, Sunitinib, Survival Rate, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute, Medicine and Health Sciences
العلاقة: https://scholarlyworks.lvhn.org/hematology-medical-oncology-division/157Test; https://pubmed.ncbi.nlm.nih.gov/30779529Test/
-
5دورية أكاديمية
المؤلفون: Bedke, Jens1 (AUTHOR) jens.bedke@med.uni-tuebingen.de, Rini, Brian I.2 (AUTHOR), Plimack, Elizabeth R.3 (AUTHOR), Stus, Viktor4 (AUTHOR), Gafanov, Rustem5 (AUTHOR), Waddell, Tom6 (AUTHOR), Nosov, Dimitry7 (AUTHOR), Pouliot, Frederic8 (AUTHOR), Soulières, Denis9 (AUTHOR), Melichar, Bohuslav10 (AUTHOR), Vynnychenko, Ihor11 (AUTHOR), Azevedo, Sergio J.12 (AUTHOR), Borchiellini, Delphine13 (AUTHOR), McDermott, Raymond S.14 (AUTHOR), Tamada, Satoshi15 (AUTHOR), Nguyen, Allison Martin16 (AUTHOR), Wan, Shuyan16 (AUTHOR), Perini, Rodolfo F.16 (AUTHOR), Rhoda Molife, L.17 (AUTHOR), Atkins, Michael B.18 (AUTHOR)
المصدر: European Urology. Oct2022, Vol. 82 Issue 4, p427-439. 13p.
مصطلحات موضوعية: *RENAL cell carcinoma, *SUNITINIB, *QUALITY of life, *PEMBROLIZUMAB, *RENAL cancer